<DOC>
	<DOCNO>NCT00303004</DOCNO>
	<brief_summary>The purpose study investigate combination treatment Bosentan Sildenafil patient Eisenmenger syndrome beneficial .</brief_summary>
	<brief_title>Combination Treatment With Bosentan Sildenafil Patients With Eisenmengers Syndrome</brief_title>
	<detailed_description>Eisenmengers syndrome condition severe pulmonary arterial hypertension due shunt blood leave side heart right side heart . When pressure pulmonary artery level systemic blood pressure , blood begin shunt right side heart leave side heart lead condition cyanosis , impaired physical capacity increase mortality ( Eisenmengers syndrome ) . Several clinical trial show beneficial effect treat patient primary pulmonary arterial hypertension Bosentan Sildenafil combination may additive even synergistic effect . No clinical trial Sildenafil Bosentan conduct patient Eisenmengers syndrome . Observational study case story indicate however effect Bosentan Sildenafil patient Eisenmengers syndrome may promising patient patient primary pulmonary arterial hypertension . We would like examine effect treat patient Eisenmengers Syndrome combination Bosentan Sildenafil . The primary end point change physical performance measure six minute walk test . Secondary end point change saturation , NYHA class , cardiac output ( cardiac catheterization innocor measurement ) , pulmonary vascular resistance ( cardiac catheterization ) shunt ratio ( MRI ) , strain right ventricle ( BNP echocardiography ) , quality life serum erythropoitin . The trial design randomize , single centre , placebo control , double blind cross study . Twenty patient Eisenmengers syndrome include . All patient treat three month Bosentan . There patient randomize receive either Sildenafil ( 50 mg tid ) placebo add therapy three month . Hereafter cross make patient combination treatment receive native treatment vice versa . Examinations primary secondary endpoint make baseline , cross end study . All titrate medication perform admittance . Patients study period close monitored registration adverse advent , physical examination blood test .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Eisenmenger Complex</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Eisenmenger syndrome Negative pregnancy test Elevated liver enzymes 3Â´times normal value Hypotension ( SBP &lt; 90 mmhg ) . Mandatory treatment nitrate Myocardial infarction within 3 month Stroke within 3 month Known allergy Bosentan Sildenafil inherit degenerative disease retina Breast feed Suspicion risc noncompliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>